23andMe, Inc., headquartered in Sunnyvale, CA, is a leading consumer genetics and research company. Founded in 2006, 23andMe's mission is to help people access, understand, and benefit from the human genome. 23andMe has pioneered direct access to genetic information as the only company with multiple Food and Drug Administration authorizations for genetic health risk reports. 23andMe has created the world's largest crowdsourced platform for genetic research, with 80% of its customers electing to participate.
Please sign in first
none
none
none
| Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
|---|---|---|---|---|
|
WOJCICKI ANNE CHIEF EXECUTIVE OFFICER |
|
7,500,000 | 2022-03-29 | 2 |
|
11,467 | 2022-03-10 | 3 | |
|
HIBBS KATHY L CHIEF LEGAL OFFICER |
|
744,304 | 2022-02-09 | 3 |
|
HILLAN KENNETH J. HEAD OF THERAPEUTICS |
|
685,504 | 2022-02-09 | 2 |
|
KOHLER FREDERICK MARK VICE PRESIDENT, PEOPLE |
|
228,502 | 2022-02-09 | 2 |
|
SCHOCH STEVEN J CHIEF FINANCIAL OFFICER |
|
708,354 | 2022-02-09 | 2 |
|
LEMON STEVEN VICE PRESIDENT, ENGINEERING |
|
584,650 | 2022-02-09 | 3 |
|
KEIM TRACY VP, CONSUMER MARKETING & BRAND |
|
399,877 | 2022-02-09 | 2 |
|
JOHNSON PAUL D VP, GENERAL MANAGER-CONSUMER |
|
1,783,721 | 2022-02-09 | 4 |
|
54,346 | 2021-12-03 | 2 | |
|
18,421 | 2021-09-14 | 2 | |
|
18,421 | 2021-09-14 | 2 | |
|
55,263 | 2021-09-14 | 2 | |
|
55,263 | 2021-09-14 | 2 | |
|
18,421 | 2021-09-14 | 2 | |
|
18,421 | 2021-09-14 | 2 | |
|
SC GLOBAL GROWTH II MANAGEMENT, L.P. SEQUOIA CAPITAL GLOBAL GROWTH FUND II, L.P. |
|
0 | 2021-06-16 | 1 |
|
SC U.S. GROWTH VII MANAGEMENT, L.P. SEQUOIA CAPITAL U.S. GROWTH FUND VII, L.P. SEQUOIA CAPITAL U.S. GROWTH VII PRINCIPALS FUND, L.P. SEQUOIA CAPITAL GROWTH FUND III |
|
0 | 2021-06-16 | 1 |
|
WOJCICKI ANNE CHIEF EXECUTIVE OFFICER |
|
3,750,581 | 2021-06-16 | 2 |
|
GRIGG MURRAY W VP - UNCONVENTIONAL RESOURCES |
|
41,718 | 2010-03-09 | 0 |
|
HANSEN JUDD A SR. VP-SHELF & ONSHORE |
|
257,181 | 2008-11-21 | 0 |
| Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
WOJCICKI ANNE - Director - Officer - > 10% Owner CHIEF EXECUTIVE OFFICER |
2022-03-30 16:23:52 -0400 | 2022-03-29 | A | 7,500,000 | a | 7,500,000 | direct |
* -
| Code | Definition |
|---|---|
| A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
| C | Conversion of derivative security |
| D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
| G | Bona fide gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
| J | Other acquisition or disposition |
| L | Small acquisition under Rule 16a-6 |
| M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
| O | Exercise of out-of-the-money derivative security |
| P | Open market or private purchase of non-derivative or derivative security |
| S | Open market or private sale of non-derivative or derivative security |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| W | Acquisition or disposition by will or the laws of descent and distribution |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
| Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
|---|---|---|---|---|
| 23ANDME HOLDING CO -CLASS A ME | 2022-05-18 20:15:05 UTC | -1.8851 | 2.7051 | 2400000 |
| 23ANDME HOLDING CO -CLASS A ME | 2022-05-18 19:45:03 UTC | -1.8851 | 2.7051 | 2400000 |
| 23ANDME HOLDING CO -CLASS A ME | 2022-05-18 19:15:03 UTC | -1.8851 | 2.7051 | 2400000 |
| 23ANDME HOLDING CO -CLASS A ME | 2022-05-18 18:45:03 UTC | -1.8851 | 2.7051 | 2300000 |
| 23ANDME HOLDING CO -CLASS A ME | 2022-05-18 18:15:03 UTC | -1.8851 | 2.7051 | 2300000 |
| 23ANDME HOLDING CO -CLASS A ME | 2022-05-18 17:45:03 UTC | -1.8851 | 2.7051 | 2300000 |
| 23ANDME HOLDING CO -CLASS A ME | 2022-05-18 17:15:03 UTC | -1.8851 | 2.7051 | 2300000 |
| 23ANDME HOLDING CO -CLASS A ME | 2022-05-18 16:45:03 UTC | -1.8116 | 2.6316 | 2300000 |
| 23ANDME HOLDING CO -CLASS A ME | 2022-05-18 16:15:03 UTC | -1.8116 | 2.6316 | 2300000 |
| 23ANDME HOLDING CO -CLASS A ME | 2022-05-18 15:45:03 UTC | -1.8116 | 2.6316 | 2200000 |
| 23ANDME HOLDING CO -CLASS A ME | 2022-05-18 15:15:03 UTC | -1.8116 | 2.6316 | 500000 |
| 23ANDME HOLDING CO -CLASS A ME | 2022-05-18 14:45:03 UTC | -2.2429 | 3.0629 | 500000 |
| 23ANDME HOLDING CO -CLASS A ME | 2022-05-18 14:15:04 UTC | -2.2429 | 3.0629 | 500000 |
| 23ANDME HOLDING CO -CLASS A ME | 2022-05-18 13:45:03 UTC | -2.2429 | 3.0629 | 500000 |
| 23ANDME HOLDING CO -CLASS A ME | 2022-05-18 13:15:03 UTC | -2.2429 | 3.0629 | 400000 |
| 23ANDME HOLDING CO -CLASS A ME | 2022-05-18 12:45:03 UTC | -2.2429 | 3.0629 | 400000 |
| 23ANDME HOLDING CO -CLASS A ME | 2022-05-17 22:15:04 UTC | -2.2429 | 3.0629 | 2800000 |
| 23ANDME HOLDING CO -CLASS A ME | 2022-05-17 21:45:04 UTC | -2.2429 | 3.0629 | 2800000 |
| 23ANDME HOLDING CO -CLASS A ME | 2022-05-17 21:15:03 UTC | -2.2429 | 3.0629 | 2800000 |
| 23ANDME HOLDING CO -CLASS A ME | 2022-05-17 20:45:03 UTC | -2.2429 | 3.0629 | 2800000 |
| Holder | Issuer | Net Short Position | Position Date | Origin |
|---|---|---|---|---|
| Series Portfolios Trust- Weiss Alternative Multi-Strategy Fund | ME | -8786.0 shares, $-41030.62 | 2022-01-31 | N-PORT |
